Navigation Links
National Pharmaceutical Council Welcomes Shire as Its Newest Member
Date:8/3/2011

WASHINGTON, Aug. 3, 2011 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today welcomed global specialty biopharmaceutical company Shire plc as a new member. Dr. Jeffrey M. Jonas, senior vice president, specialty pharma R&D, will serve as Shire's representative on the NPC board of directors.

"The last few years have brought change to the health care environment that has left many important questions unresolved.  For the pharmaceutical industry, how comparative effectiveness research will be conducted and used is critical. We welcome Shire and look forward to their contribution to our shared mission of helping to answer these questions and chart the future," said NPC President Dan Leonard.

Shire, with facilities in Pennsylvania and Massachusetts, is focused on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. 

"Shire is very supportive of NPC's focus on evidence-based medicine and on policy research related to comparative effectiveness research, pharmaceutical innovation and the value of medicines," said Dr. Jonas. "We're pleased to be a part of this organization and look forward to working with NPC on issues affecting the pharmaceutical industry."

In becoming an NPC member, Shire joins with other leading research-based pharmaceutical companies, including Abbott Laboratories, Astra Zeneca LP, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals Inc., Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., Eisai inc., GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Otsuka America Pharmaceutical, Inc., Pfizer Inc, sanofi-aventis, and Teva Neuroscience.

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org.


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FedEx Donates $5 Million and MD-10-30 Aircraft to ORBIS International
2. FDA, International Counterparts Report Progress on Drug Inspection Collaboration
3. Chindex International, Inc. to Report Financial Results for the Second Quarter and First Half of 2011
4. Medela Announces 2011 Breastfeeding Hall of Excellence Inductees to Nationally Recognize Exceptional Breastfeeding Advocates
5. Elsevier Supports International Medical Corps Through Act to Save a Life Campaign
6. CVS Caremark Showcases Workplace and Marketplace Diversity at 2011 National Urban League Conference
7. H. D. Smith Reorganizes National Leadership for Continued Focus on Regional Customer Needs; Support Company Growth
8. Vystar® Corporation Spotlights Advantages of Vytex® NRL at the 13th Annual International Latex Conference
9. Pharmaceutics International, Inc. (Pii) Expands Drug Formulation and Manufacturing Capabilities with Hot Melt Extrusion Technology
10. Epitomics Releases New Antibodies Developed With the National Cancer Institutes Center for Cancer Research
11. Aeras and China National Biotech Group Sign Memorandum of Understanding for TB Vaccine R&D Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... -- The concept of rare diseases and the idea that ... has been taking shape in Europe ... initiatives related to orphan medicinal products have been emerging at ... states individually. Many member states in the EU have led ... medicinal products, the result of which took the shape of ...
(Date:12/2/2016)... -- Around the corners of world, cancer has infused ... present over earth. Cancer has become one of those ... time this is because of the increasing incidence rates ... steady increase in global cancer incidence with its associated ... of treatment, there is increasing interest in this stringent ...
(Date:12/2/2016)... 2, 2016 bioLytical Laboratories (das "Unternehmen"), ein Weltführer ... seinen  INSTI HIV-Selbsttests  in einer Version mit geringeren Kosten einzuführen.  ... ... New: INSTI Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444833 ) ...
Breaking Medicine Technology:
(Date:12/2/2016)... CO (PRWEB) , ... December 02, 2016 , ... Advanced ... announced it has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief ... for Advanced, Inc. , Jason brings extensive financial and operational leadership experience to ...
(Date:12/2/2016)... ... 2016 , ... The annual time frame to change Medicare health and prescription ... December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan ... to make changes during this period order for their new policy to go into ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... two ostomy patients, standing as living proof that attitude and determination can combine ... and issues that spike around the holidays. This campaign will offer patients a ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet ... in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition ... lives. “We are prolonging life 6 years in the last 3 decades,” says ...
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
Breaking Medicine News(10 mins):